1. Home
  2. PTGX vs SEMR Comparison

PTGX vs SEMR Comparison

Compare PTGX & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • SEMR
  • Stock Information
  • Founded
  • PTGX 2006
  • SEMR 2008
  • Country
  • PTGX United States
  • SEMR United States
  • Employees
  • PTGX N/A
  • SEMR N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • PTGX Health Care
  • SEMR Technology
  • Exchange
  • PTGX Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • PTGX 2.8B
  • SEMR 1.9B
  • IPO Year
  • PTGX 2016
  • SEMR 2021
  • Fundamental
  • Price
  • PTGX $47.91
  • SEMR $13.28
  • Analyst Decision
  • PTGX Strong Buy
  • SEMR Buy
  • Analyst Count
  • PTGX 7
  • SEMR 8
  • Target Price
  • PTGX $52.83
  • SEMR $15.38
  • AVG Volume (30 Days)
  • PTGX 450.1K
  • SEMR 322.1K
  • Earning Date
  • PTGX 11-08-2024
  • SEMR 11-07-2024
  • Dividend Yield
  • PTGX N/A
  • SEMR N/A
  • EPS Growth
  • PTGX N/A
  • SEMR N/A
  • EPS
  • PTGX 2.75
  • SEMR 0.10
  • Revenue
  • PTGX $319,120,000.00
  • SEMR $338,875,000.00
  • Revenue This Year
  • PTGX $400.33
  • SEMR $24.08
  • Revenue Next Year
  • PTGX N/A
  • SEMR $19.38
  • P/E Ratio
  • PTGX $17.54
  • SEMR $127.37
  • Revenue Growth
  • PTGX 125.73
  • SEMR 20.97
  • 52 Week Low
  • PTGX $13.76
  • SEMR $7.36
  • 52 Week High
  • PTGX $48.89
  • SEMR $16.42
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 60.40
  • SEMR 44.11
  • Support Level
  • PTGX $45.33
  • SEMR $12.61
  • Resistance Level
  • PTGX $48.89
  • SEMR $13.20
  • Average True Range (ATR)
  • PTGX 1.28
  • SEMR 0.34
  • MACD
  • PTGX 0.11
  • SEMR -0.02
  • Stochastic Oscillator
  • PTGX 77.11
  • SEMR 40.22

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the provision of an online visibility management software-as-a-service platform. Its platform enables subscribers to improve their online visibility and drive traffic, including on their websites and social media pages, and distribute highly relevant content to their customers on a targeted basis across various channels to drive high-quality traffic and measure the effectiveness of their digital marketing campaigns. Geographically, it generates revenues from the US, the UK, and other regions.

Share on Social Networks: